REQUEST A DEMO
Total
USD $0.00
Search more companies

Gold Billion Pharma Sdn. Bhd. (Malaysia)

Main Activities: All Other Miscellaneous Ambulatory Health Care Services
Full name: Gold Billion Pharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Gold Billion Pharma Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Seri Kembangan. The company operates in the All Other Miscellaneous Ambulatory Health Care Services sector. The company was established on November 04, 2015. In 2021, the company reported a net sales revenue drop of 15.23%. Over the same period, its total assets grew by 10.31%. In 2021, Gold Billion Pharma Sdn. Bhd.’s net profit margin decreased by 0.39%.

Headquarters
No.29-6, Jalan Sp 2/1, Taman Serdang Perdana, Seksyen 2
Seri Kembangan; Selangor; Postal Code: 43300

Contact Details: Purchase the Gold Billion Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Gold Billion Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Gold Billion Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
November 04, 2015
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Gold Billion Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-15.23%
Total operating revenue
-15.23%
Operating profit (EBIT)
-15.49%
EBITDA
-13.2%
Net Profit (Loss) for the Period
-23.73%
Total assets
10.31%
Total equity
21.64%
Operating Profit Margin (ROS)
-0.02%
Net Profit Margin
-0.39%
Return on Equity (ROE)
-10.59%
Debt to Equity Ratio
28.63%
Quick Ratio
0.08%
Cash Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?